Company Overview

Assure Holdings Corp. is a healthcare services company focused on intraoperative neuromonitoring (IONM) and related neurological services used during complex surgical procedures. The company operates within the healthcare services and medical technology support industries, primarily supporting hospitals, ambulatory surgery centers, and surgeons by providing real-time neurophysiological monitoring intended to reduce the risk of neurological injury during surgery. Public disclosures and market filings identify IONM services as the company’s principal revenue driver, with additional activity in remote neurology interpretation and related clinical support services.

The company’s business model is centered on providing technical staff, monitoring platforms, and physician oversight during surgical procedures involving the spine, brain, vascular system, and peripheral nerves. Assure Holdings evolved through acquisitions and operational expansion in the U.S. IONM market, positioning itself as a specialized outsourced provider to healthcare systems seeking clinical monitoring capabilities without maintaining extensive in-house programs. Its strategic positioning has historically emphasized physician relationships, scalable monitoring infrastructure, and regional service coverage in the United States.

Business Operations

Assure Holdings generates revenue primarily through its Intraoperative Neuromonitoring (IONM) operations, which involve monitoring neural pathways during surgery using electrophysiological technologies and real-time interpretation by qualified clinicians and neurologists. The company’s operating model combines technologists present in operating rooms with remote physician oversight, enabling support across multiple healthcare facilities. Public filings indicate that reimbursement from commercial insurers, government healthcare programs, and healthcare providers represents a core component of revenue generation.

Operations are concentrated primarily in the United States, where the company supports surgical procedures across multiple states through clinical personnel networks and contracted physician relationships. Assure Holdings has historically utilized affiliated professional entities and physician partnerships to deliver interpretation services in compliance with healthcare regulatory frameworks. The company has also pursued operational scale through acquisitions of regional IONM businesses and integration of monitoring platforms, although some historical acquisition details and current subsidiary structures are not consistently detailed across all public sources. Data inconclusive based on available public sources regarding the full current subsidiary portfolio.

Strategic Position & Investments

Assure Holdings’ strategic direction has focused on expanding procedure volume, improving reimbursement collections, increasing operating efficiency, and strengthening relationships with hospitals and surgeons. Company disclosures and investor communications have emphasized technology-enabled monitoring workflows, optimized billing operations, and broader geographic penetration within the U.S. surgical services market. The company has also highlighted efforts to streamline operations and improve financial performance amid reimbursement and healthcare cost pressures affecting the broader IONM sector.

Historically, Assure Holdings pursued growth through acquisitions of regional neuromonitoring providers and physician-network expansion. The company has also referenced investments in remote monitoring infrastructure and data systems supporting real-time interpretation services. Emerging areas of focus have included operational digitization and scalable remote neurology capabilities tied to procedural healthcare services. However, public information regarding large-scale international investments, major venture holdings, or diversified portfolio companies remains limited. Data inconclusive based on available public sources regarding material investments outside core IONM operations.

Geographic Footprint

Assure Holdings is headquartered in the United States, with operations concentrated across multiple U.S. healthcare markets. The company’s service footprint has historically included hospitals and surgical centers in regions with significant spine and neurological surgery volumes. Public filings and investor materials indicate that its business activities are overwhelmingly domestic rather than multinational.

While Assure Holdings has been publicly traded in both U.S. and Canadian markets at various points, there is limited evidence of substantial operational infrastructure outside the United States. The company’s market presence is therefore best characterized as U.S.-focused healthcare services delivery rather than a globally diversified medical technology enterprise. Data inconclusive based on available public sources regarding any material non-U.S. operating assets or international clinical operations.

Leadership & Governance

Assure Holdings has operated under a management team with experience in healthcare operations, medical services, reimbursement strategy, and public company administration. Corporate governance disclosures indicate that leadership priorities have included operational discipline, procedure growth, reimbursement optimization, and expansion of provider relationships within the surgical ecosystem. The company’s strategic vision has generally emphasized scalable clinical service delivery supported by technology and physician integration.

Key executives and leadership figures identified in recent public disclosures include:

• John A. Farlinger – Executive Chairman
• Dan Scavilla – Chief Executive Officer
• Michael McConnell – Chief Financial Officer

Founder information and historical executive composition vary across public filings and corporate periods. Data inconclusive based on available public sources regarding a single recognized founder or founder-led governance structure.